The M3-TT Vaccine Decreases the Antinociceptive Effects of Morphine and Heroin in Mice

Barbosa-Méndez, Susana; Matus-Ortega, Maura; Miramontes, Ricardo Hernández; Salazar-Juárez, Alberto

doi:10.1007/s11469-021-00621-z

Cited by 2 publications

(1 citation statement)

References 90 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In this sense, our laboratory previously reported the efficacy of the tetanus toxoid-conjugated morphine vaccine. 51–57 The M 6 -TT vaccine was capable of generating high titers of antibodies capable of capturing morphine, heroin, and their metabolites 51 , 52 and reducing heroin- or morphine-induced antinociception, 53 , 55 , 56 self-administration, 51 , 52 and locomotor activity, 54 , 57 in Wistar rats and BALB/c, C57Bl/6 and DBA/2 mice. 54 …”

Section: Introductionmentioning

confidence: 99%

COT-TT vaccine attenuates cocaine-seeking and cocaine-conditioned place preference in rats

Barbosa-Méndez,

Matus-Ortega,

Hernandez-Miramontes

et al. 2024

Human Vaccines & Immunotherapeutics

Self Cite

View full text Add to dashboard Cite

Vaccination active, promising alternative immunological strategy to treat of CUD. Various models of cocaine vaccines have been evaluated in animals and humans with relative success. In this sense, it is necessary to improve or optimize the cocaine vaccines already evaluated. Our laboratory previously reported the efficacy of the tetanus toxoid-conjugated morphine vaccine (M 6 -TT). The M 6 -TT vaccine can generate high titers of antibodies and reduce heroin-induced behavioral effects in rodents. So, it would be plausible to assume that if we modify the M 6 -TT vaccine by changing the hapten and maintaining the rest of the structural elements of the vaccine, we will maintain the properties of the M 6 -TT vaccine (high antibody titers). The objective of this study was to determine whether the antibodies generated by a tetanus toxoid-conjugated cocaine vaccine (COC-TT) can recognize and capture cocaine and decrease the cocaine-induced reinforcing effects. Male Wistar rats were immunized with the COC-TT. A solid-phase antibody-capture ELISA was used to monitor antibody titer responses after each booster dose in vaccinated animals. The study used cocaine self-administration and place-preference testing to evaluate the cocaine-reinforcing effects. The COC-TT vaccine could generate high levels of anti-cocaine antibodies. The antibodies reduced the cocaine self-administration and cocaine place preference. In addition, they decreased the cocaine-induced Fos protein expression. These findings suggest that the COC-TT vaccine generates a robust immunogenic response capable of reducing the reinforcing effects of cocaine, which supports its possible future use in clinical trials in patients with CUD.

show abstract